S&P Futures
5,526.25 -3.75 (-0.07%) Dow Futures
41,032.00 -19.00 (-0.05%) Nasdaq Futures
18,935.75 -26.75 (-0.14%) Russell 2000 Futures
2,145.10 -4.70 (-0.22%) Crude Oil
69.52 +0.32 (+0.46%) Gold
2,533.00 +7.00 (+0.28%)
The Fight Against COVID19
23.84k followers ? 13 symbols Watchlist by TREA
Follow this list to discover and track the stock of publicly traded companies with COVID-19 related treatment and healthcare plans.
Curated by TREA
Performance
| Watchlist | Change Today | 1 Month Return | 1 Year Return | Total Return |
|---|---|---|---|---|
| The Fight Against COVID19 | +0.06% | - | - | - |
| ^GSPC | -0.16% | +6.44% | +22.75% | +5835.56% |
13 Symbols
| Symbol | Company Name | Last Price | Change | % Change | Market Time | Volume | Avg Vol (3 month) | Market Cap |
|---|---|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | 167.36 | +0.20 | +0.12% | 4:00 PM EDT | 6.70M | 6.88M | 402.88B |
| ABBV | AbbVie Inc. | 197.01 | -0.68 | -0.34% | 4:00 PM EDT | 4.19M | 5.23M | 347.99B |
| PFE | Pfizer Inc. | 28.39 | +0.09 | +0.32% | 4:00 PM EDT | 23.38M | 32.18M | 160.88B |
| SNY | Sanofi | 58.53 | +1.00 | +1.74% | 4:00 PM EDT | 1.99M | 2.30M | 146.71B |
| REGN | Regeneron Pharmaceuticals, Inc. | 1179.37 | +10.56 | +0.90% | 4:00 PM EDT | 292.11k | 452.37k | 130.01B |
| GILD | Gilead Sciences, Inc. | 79.13 | -0.57 | -0.72% | 4:00 PM EDT | 3.88M | 7.03M | 98.52B |
| GSK | GSK plc | 44.26 | +0.82 | +1.89% | 4:00 PM EDT | 2.84M | 3.44M | 90.27B |
| TAK | Takeda Pharmaceutical Company Limited | 14.98 | +0.06 | +0.40% | 4:00 PM EDT | 972.52k | 2.19M | 47.50B |
| MRNA | Moderna, Inc. | 72.49 | -0.45 | -0.62% | 4:00 PM EDT | 4.22M | 3.80M | 27.86B |
| BNTX | BioNTech SE | 89.02 | +1.02 | +1.16% | 4:00 PM EDT | 454.78k | 658.39k | 21.17B |
| NVAX | Novavax, Inc. | 11.87 | -0.80 | -6.31% | 4:00 PM EDT | 12.15M | 8.69M | 1.90B |
| VIR | Vir Biotechnology, Inc. | 7.6 | -0.18 | -2.31% | 4:00 PM EDT | 523.54k | 1.04M | 1.06B |
| INO | Inovio Pharmaceuticals, Inc. | 6.575 | +0.14 | +2.26% | 4:00 PM EDT | 253.93k | 370.81k | 170.72M |
The Wall Street JournalJohnson & Johnson Wins Over Longtime Holdout for Talc Settlement
Tort lawyer Allen Smith now backs J&J’s settlement plan after the company raised its offer to roughly $9 billion.
ZacksPfizer (PFE) Ascends While Market Falls: Some Facts to Note
In the most recent trading session, Pfizer (PFE) closed at $28.39, indicating a +0.32% shift from the previous trading day.
ReutersJohnson & Johnson adds $1.1 billion to proposed talc settlement
(Reuters) -Johnson & Johnson plans to pay an additional $1.1 billion to resolve tens of thousands of legal actions alleging its baby powder and other talc products caused cancer, two people familiar with the matter said. The increase would boost the size of the settlement to more than $9 billion paid over 25 years. J&J on Wednesday said it reached an agreement with a plaintiffs' lawyer representing 12,000 clients to recommend the settlement offer to them, adding to support already received from other claimants.
